Overview
Alpha-N-acetylgalactosaminidase (NAGA) deficiency is a rare lysosomal storage disorder characterized by reduced enzymatic activity leading to the accumulation of specific glycopeptides, manifesting as angiokeratoma corporis diffusum and glycopeptiduria 1.Diagnosis
Enzyme Assay: Measure alpha-N-acetylgalactosaminidase activity in leukocytes or fibroblasts, typically showing less than 2% of normal activity 1.
Immunoblotting: Confirm absence of detectable immunoreactive enzyme protein 1.
Urinary Analysis: Identify characteristic O-linked sialopeptides in urine indicative of glycopeptiduria 1.
Ultrastructural Examination: Look for lysosomal inclusions containing amorphous and filamentous material in skin and blood cells 1.Management
Supportive Care: Focus on managing symptoms and complications, including dermatological care for angiokeratomas 1.
Genetic Counseling: Essential for families, given the autosomal recessive inheritance pattern 1.
Monitoring: Regular follow-up to assess for neurological involvement and other systemic manifestations 1.Special Populations
Pediatrics: Early diagnosis and monitoring crucial due to potential for evolving neurological symptoms 1.
Comorbidities: No specific management details provided for comorbidities in the abstract 1.Key Recommendations
Confirm diagnosis through enzyme activity measurement and immunoblotting of alpha-N-acetylgalactosaminidase 1 (Evidence: Strong).
Include genetic counseling for affected families to understand inheritance risks 1 (Evidence: Expert opinion).
Implement regular clinical monitoring to detect early signs of neurological complications 1 (Evidence: Moderate).References
1 Kanzaki T, Wang AM, Desnick RJ. Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria. The Journal of clinical investigation 1991. link